002172 澳洋健康
已收盘 07-19 15:00:00
资讯
新帖
简况
澳洋健康:目前吉林澳洋生物科技有限公司未涉及合成生物技术
证券之星 · 06-28
澳洋健康:目前吉林澳洋生物科技有限公司未涉及合成生物技术
澳洋健康最新公告:子公司拟增资扩股 引入核心人员持股平台
证券之星 · 06-07
澳洋健康最新公告:子公司拟增资扩股 引入核心人员持股平台
澳洋健康回复年报问询函:公司营业收入下降系处置化学纤维业务所致
证券之星 · 06-05
澳洋健康回复年报问询函:公司营业收入下降系处置化学纤维业务所致
澳洋健康(002172.SZ)发布一季度业绩,净利润3073.94万元,下降15.39%
智通财经 · 04-29
澳洋健康(002172.SZ)发布一季度业绩,净利润3073.94万元,下降15.39%
澳洋健康(002172.SZ)发布2023年度业绩,扭亏为盈至4968.16万元
智通财经 · 04-26
澳洋健康(002172.SZ)发布2023年度业绩,扭亏为盈至4968.16万元
澳洋健康(002172.SZ)拟收购安徽大岭51%股权 结合其山泉水业务丰富“健康”理念产品
智通财经网 · 02-22
澳洋健康(002172.SZ)拟收购安徽大岭51%股权 结合其山泉水业务丰富“健康”理念产品
概念掘金 | 银发经济首部政策出台!万亿市场蕴含哪些新机遇?
格隆汇 · 01-16
概念掘金 | 银发经济首部政策出台!万亿市场蕴含哪些新机遇?
加载更多
公司概况
公司名称:
江苏澳洋健康产业股份有限公司
所属行业:
化学纤维制造业
上市日期:
2007-09-21
主营业务:
江苏澳洋健康产业股份有限公司主营业务为健康医疗。公司主要产品及服务为医药物流、医疗服务、康养服务。公司在张家港市已拥有澳洋医院、杨舍分院、三兴分院、顺康医院四家医院。其中,澳洋医院被评为三级综合医院并通过JCI认证医院复评,助力于提升上市公司在大健康领域的知名度,树立了良好的企业形象,对公司的经营发展起到了积极影响;荣获第七届全国医院品管圈大赛三等奖、改善医疗服务示范医院、苏州市级临床重点专科、中国上市医服务企csr 30强,入围了“2019年医院品管圈比赛优秀圈组一等奖”。
发行价格:
14.85
{"stockData":{"symbol":"002172","market":"SZ","secType":"STK","nameCN":"澳洋健康","latestPrice":2.35,"timestamp":1721372604000,"preClose":2.37,"halted":0,"volume":7783050,"delay":0,"floatShares":765000000,"shares":766000000,"eps":0.0576,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.02,"latestTime":"07-19 15:00:00","open":2.35,"high":2.38,"low":2.32,"amount":18247200,"amplitude":0.0253,"askPrice":2.36,"askSize":4264,"bidPrice":2.35,"bidSize":328,"shortable":0,"etf":0,"ttmEps":0.0576,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721611800000},"adr":0,"adjPreClose":2.37,"symbolType":"stock","openAndCloseTimeList":[[1721352600000,1721359800000],[1721365200000,1721372400000]],"highLimit":2.61,"lowLimit":2.13,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":765732360,"pbRate":14.56,"roa":"--","roe":"28.14%","epsLYR":0.06,"committee":0.223946,"marketValue":1799000000,"floatMarketCap":1798000000,"peRate":40.798612,"changeRate":-0.0084,"turnoverRate":0.0102,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-07-22。"},"requestUrl":"/m/hq/s/002172","defaultTab":"news","newsList":[{"id":"2446710765","title":"澳洋健康:目前吉林澳洋生物科技有限公司未涉及合成生物技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2446710765","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446710765?lang=zh_cn&edition=full","pubTime":"2024-06-28 18:01","pubTimestamp":1719568899,"startTime":"0","endTime":"0","summary":"公司通过积极开拓大健康领域业务、持续改善经营状况以及优化财务结构等多层次多方面举措来提高公司竞争力和挖掘发展潜力。后续如有相关资本运作及重大业务开展公司将严格按照相关规定及时履行信息披露义务。目前公司主营业务为医疗业务和医药流通业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062800040561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","159837","002172","BK0208","BK0096"],"gpt_icon":0},{"id":"2441034160","title":"澳洋健康最新公告:子公司拟增资扩股 引入核心人员持股平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2441034160","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441034160?lang=zh_cn&edition=full","pubTime":"2024-06-07 16:42","pubTimestamp":1717749748,"startTime":"0","endTime":"0","summary":"澳洋健康公告,公司部分董事、核心管理人员及下属子公司医疗专家及核心岗位人员成立了张家港市聚心投资合伙企业与张家港市聚力投资合伙企业向公司全资子公司澳洋医院增资。增资金额分别为3060万元和4850万元。本次增资完成后,澳洋医院原股东江苏澳洋医疗产业发展有限公司持有澳洋医院95.01%的股权,聚心投资持有澳洋医院1.93%的股权,聚力投资持有澳洋医院3.06%的股权。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060700031075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0208","002172","BK0077"],"gpt_icon":0},{"id":"2441244078","title":"澳洋健康回复年报问询函:公司营业收入下降系处置化学纤维业务所致","url":"https://stock-news.laohu8.com/highlight/detail?id=2441244078","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441244078?lang=zh_cn&edition=full","pubTime":"2024-06-05 16:35","pubTimestamp":1717576529,"startTime":"0","endTime":"0","summary":"澳洋健康回复深交所年报问询函,公司营业收入于2022年发生大幅下降,从上表的收入结构分析,2019年至2021年公司化学纤维的平均收入为115,091.60万元,但2022年化学纤维的营业收入较2021年下降了103,658.47万元,占当年营业收入下降总额的102.88%,且2023年化学纤维收入进一步下降为1.74万元。由于公司营业收入下降主要系处置化学纤维业务所致,因此营业收入下降是阶段性的、非线性的以及不可持续的。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060500032451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002172"],"gpt_icon":0},{"id":"2431885605","title":"澳洋健康(002172.SZ)发布一季度业绩,净利润3073.94万元,下降15.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431885605","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431885605?lang=zh_cn&edition=full","pubTime":"2024-04-29 16:52","pubTimestamp":1714380758,"startTime":"0","endTime":"0","summary":"智通财经APP讯,澳洋健康(002172.SZ)发布2024年第一季度报告,该公司营业收入为5.82亿元,同比增长6.95%。归属于上市公司股东的净利润为3073.94万元,同比减少15.39%。归属于上市公司股东的扣除非经常性损益的净利润为2785.53万元,同比增长138.50%。基本每股收益为0.04元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114240.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002172"],"gpt_icon":0},{"id":"2430297276","title":"澳洋健康(002172.SZ)发布2023年度业绩,扭亏为盈至4968.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430297276","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430297276?lang=zh_cn&edition=full","pubTime":"2024-04-26 20:29","pubTimestamp":1714134596,"startTime":"0","endTime":"0","summary":"智通财经APP讯,澳洋健康(002172.SZ)发布2023年年度报告,报告期内,公司实现营业收入21.74亿元,同比增长7.54%。实现归属于上市公司股东的净利润4968.16万元。实现归属于上市公司股东的扣除非经常性损益的净利润2729.42万元。基本每股收益为0.06元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1112246.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0208","BK0096","002172","BK0077"],"gpt_icon":0},{"id":"2413269609","title":"澳洋健康(002172.SZ)拟收购安徽大岭51%股权 结合其山泉水业务丰富“健康”理念产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2413269609","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413269609?lang=zh_cn&edition=full","pubTime":"2024-02-22 16:16","pubTimestamp":1708589760,"startTime":"0","endTime":"0","summary":"本次收购完成后,安徽大岭将成为公司的控股子公司,并纳入公司合并报表范围。公司表示,安徽大岭以“天然、健康”等理念经营山泉水业务,与公司的“大健康”产业相契合。此次收购安徽大岭股权,将丰富公司“健康”理念产品,为公司创造新的利润增长点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-22/doc-inaixcqi1826970.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-22/doc-inaixcqi1826970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002172","BK0208","BK0077","BK0096"],"gpt_icon":0},{"id":"2403077967","title":"概念掘金 | 银发经济首部政策出台!万亿市场蕴含哪些新机遇?","url":"https://stock-news.laohu8.com/highlight/detail?id=2403077967","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2403077967?lang=zh_cn&edition=full","pubTime":"2024-01-16 09:23","pubTimestamp":1705368221,"startTime":"0","endTime":"0","summary":"大势所趋\n","market":"us","thumbnail":"https://img3.gelonghui.com/08dea-77b0eb32-56b7-4a3d-ab92-8c0a9040b89e.jpg?guru_height=720&guru_width=1080","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/08dea-77b0eb32-56b7-4a3d-ab92-8c0a9040b89e.jpg?guru_height=720&guru_width=1080"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/684708","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0251","BK0070","BK0096","BK0185","002178","BK0208","BK0050","BK0058","301061","BK0139","BK0146","BK0114","BK0260","002172","BK0224","002162","BK0221","BK0077","BK0028","301320","BK0113","BK0197","BK0231","600239","BK0021","BK0273","002223","BK0134","301337","BK0188","BK0053","BK0235"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2007-09-21","address":"江苏省苏州市张家港市杨舍镇塘市镇中路018号","stockEarnings":[{"period":"1week","weight":-0.0447},{"period":"1month","weight":-0.1098},{"period":"3month","weight":-0.1577},{"period":"6month","weight":-0.4212},{"period":"1year","weight":-0.3266},{"period":"ytd","weight":-0.3799}],"companyName":"江苏澳洋健康产业股份有限公司","boardCode":"AI0028","perCapita":"12775股","boardName":"化学纤维制造业","registeredCapital":"76573万元","compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0118},{"period":"3month","weight":-0.0271},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":0.0025}],"survey":" 江苏澳洋健康产业股份有限公司主营业务为健康医疗。公司主要产品及服务为医药物流、医疗服务、康养服务。公司在张家港市已拥有澳洋医院、杨舍分院、三兴分院、顺康医院四家医院。其中,澳洋医院被评为三级综合医院并通过JCI认证医院复评,助力于提升上市公司在大健康领域的知名度,树立了良好的企业形象,对公司的经营发展起到了积极影响;荣获第七届全国医院品管圈大赛三等奖、改善医疗服务示范医院、苏州市级临床重点专科、中国上市医服务企csr 30强,入围了“2019年医院品管圈比赛优秀圈组一等奖”。","serverTime":1721471002361,"listedPrice":14.85,"stockholders":"59900人(较上一季度增加13.66%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"澳洋健康(002172)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供澳洋健康(002172)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"澳洋健康,002172,澳洋健康股票,澳洋健康股票老虎,澳洋健康股票老虎国际,澳洋健康行情,澳洋健康股票行情,澳洋健康股价,澳洋健康股市,澳洋健康股票价格,澳洋健康股票交易,澳洋健康股票购买,澳洋健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"澳洋健康(002172)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供澳洋健康(002172)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}